[HTML][HTML] Clinical Utility of the Sivelestat for the Treatment of ALI/ARDS: Moving on in the Controversy?
Q Ding, Y Wang, C Yang, X Li, X Yu - Intensive Care Research, 2023 - Springer
Acute respiratory distress syndrome (ARDS) is a serious condition that can arise following
direct or indirect acute lung injury (ALI). It is heterogeneous and has a high mortality rate …
direct or indirect acute lung injury (ALI). It is heterogeneous and has a high mortality rate …
Clinical Utility of the Sivelestat for the Treatment of ALI/ARDS: Moving on in the Controversy?
Q Ding, Y Wang, C Yang, X Li… - Intensive care …, 2023 - pubmed.ncbi.nlm.nih.gov
Acute respiratory distress syndrome (ARDS) is a serious condition that can arise following
direct or indirect acute lung injury (ALI). It is heterogeneous and has a high mortality rate …
direct or indirect acute lung injury (ALI). It is heterogeneous and has a high mortality rate …
[HTML][HTML] Clinical Utility of the Sivelestat for the Treatment of ALI/ARDS: Moving on in the Controversy?
Q Ding, Y Wang, C Yang, X Li, X Yu - Intensive Care Research, 2023 - ncbi.nlm.nih.gov
Acute respiratory distress syndrome (ARDS) is a serious condition that can arise following
direct or indirect acute lung injury (ALI). It is heterogeneous and has a high mortality rate …
direct or indirect acute lung injury (ALI). It is heterogeneous and has a high mortality rate …
Clinical Utility of the Sivelestat for the Treatment of ALI/ARDS: Moving on in the Controversy?
Q Ding, Y Wang, C Yang, X Li, X Yu - Intensive Care Research, 2022 - europepmc.org
Acute respiratory distress syndrome (ARDS) is a serious condition that can arise following
direct or indirect acute lung injury (ALI). It is heterogeneous and has a high mortality rate …
direct or indirect acute lung injury (ALI). It is heterogeneous and has a high mortality rate …
[PDF][PDF] Clinical Utility of the Sivelestat for the Treatment of ALI/ARDS: Moving on in the Controversy?
Q Ding, Y Wang, C Yang, X Li, X Yu - 2022 - d-nb.info
Acute respiratory distress syndrome (ARDS) is a serious condition that can arise following
direct or indirect acute lung injury (ALI). It is heterogeneous and has a high mortality rate …
direct or indirect acute lung injury (ALI). It is heterogeneous and has a high mortality rate …
Clinical Utility of the Sivelestat for the Treatment of ALI/ARDS: Moving on in the Controversy?
Q Ding, Y Wang, C Yang, X Li, X Yu - Intensive Care Research, 2022 - europepmc.org
Acute respiratory distress syndrome (ARDS) is a serious condition that can arise following
direct or indirect acute lung injury (ALI). It is heterogeneous and has a high mortality rate …
direct or indirect acute lung injury (ALI). It is heterogeneous and has a high mortality rate …